Monoclonal Antibody and Biosensor Core
Monoclonal Antibody and Biosensor Core
批准号:
7656437
负责人:
James E Crowe
金额:
$38.6万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-15 至 2009-02-28
关键词:
AloralAntibodiesAntigensBacillus anthracis sporeBacterial AdhesinsBindingBiological AssayBiosensorCell LineComplementCowpoxCytokine GeneDatabasesDetectionDevelopmentDiagnosisDiagnosticElementsHumanIRAK3 geneImmuneImmune responseImmunizationImmunohistochemistryInstitutionInterleukin-10Interleukin-4Macaca mulattaMonoclonal AntibodiesMusNaturePathogenesisPhage DisplayPoxviridaeProductionProtein FragmentProteinsRangeRattusReagentReceptor GeneRecombinantsRepliconResearchResearch Project GrantsRetroviridaeSECTM1 geneServicesSourceSystemTestingTherapeuticVacciniaWorkYersinia pestisanthrax protective factorconceptinterleukin-18 receptornovelprogramsrepositorysensorsuccessvaccine developmentvector
中文摘要
SERCEB的计划对单抗有直接和预期的需求
用于研究发病机制、免疫反应、疫苗开发、
治疗和诊断学。这些试剂和生物识别元件将对
建议的研究项目取得成功。单抗的性质和来源
所需的将取决于研究计划的目标,范围从小鼠单克隆
人或人源化小鼠抗体的免疫组织化学和检测
用于治疗学的发展。SERCEB的机构内有广泛的专业知识
在单抗的开发、测试和使用中。单抗研发方面的专业知识包括
人、小鼠、人源化小鼠、恒河猴和噬菌体展示人和小鼠的腹肌和
ScFv.最后,抗体将是可交付的,可能立即应用于
治疗和诊断学。建议的核心C是一个分布式核心,它使用已建立的
在几个机构设立实验室,以提供所需的每一项服务。核心将提供所有
SERCEB所需的生物识别元素,并将把它们开发成新的检测方法和
生物传感器。
核心有四个具体目标。
目的1.制备抗痘病毒中和靶和炭疽保护作用的人源单抗
抗原。
目的2.为SERCEB研究项目制备高质量的单抗试剂。
目标3.利用新型单抗开发用于诊断或检测选定试剂的生物传感器
在SERCEB中提供
目标4.在SERCEB内为单抗开发一个数据库和储存库,可以
在各机构之间共享,以促进其他科学项目。
英文摘要
The programs of the SERCEB have immediate and projected requirements for monoclonal
antibodies (mAbs) for studies of pathogenesis, immune response, vaccine development,
therapeutics and diagnostics. These reagents and bio-recognition elements will be vital to the
success of proposed research projects. The nature and source of the monoclonal antibodies
required will depend on the objective of the research program, ranging from murine monoclonal
antibodies for immunohistochemistry and detection to human or humanized mouse antibodies
for development of therapeutics. Broad expertise exists within the institutions of the SERCEB
in mAb development, testing and use. The spectrum of expertise in mAb development includes
human, mouse, humanized mouse, rhesus, and phage display human and mouse F abs and
ScFv. Finally, the antibodies will be deliverables that may have immediate application in
therapeutics and diagnostics. The proposed Core C is a distributed core that uses established
labs at several institutions to provide each of the needed services. The Core will provide all of
the biorecognition elements needed in the SERCEB and will develop them into new assays and
biosensors.
The core has four Specific Aims.
Aim 1. Generate human mAbs to poxvirus neutralization targets and anthrax protective
antigen.
Aim 2. Generate high-quality mAb reagents for SERCEB research programs.
Aim 3. Develop biosensors for diagnostics or detection of select agents using novel mAbs
available in the SERCEB
Aim 4. To develop a database and repository for mAbs within the SERCEB that can be
shared across institutions, to facilitate the other scientific programs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Monoclonal Antibodies for Encephalitic Alphaviruses
-
批准号:10539155
-
项目类别:
-
资助金额:$85.81万
-
财政年份:2022
-
负责人:James E Crowe
-
依托单位:
Human Monoclonal Antibodies for Encephalitic Alphaviruses
-
批准号:10669266
-
项目类别:
-
资助金额:$81.03万
-
财政年份:2022
-
负责人:James E Crowe
-
依托单位:
Structure based design of trimer interface epitope focused universal influenza vaccines
-
批准号:10361516
-
项目类别:
-
资助金额:$122.11万
-
财政年份:2020
-
负责人:James E Crowe
-
依托单位:
Structure based design of trimer interface epitope focused universal influenza vaccines
-
批准号:10576343
-
项目类别:
-
资助金额:$121.34万
-
财政年份:2020
-
负责人:James E Crowe
-
依托单位:
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Virus Neutralization
-
批准号:10021075
-
项目类别:
-
资助金额:$62.84万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses
-
批准号:10576280
-
项目类别:
-
资助金额:$246.43万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
-
批准号:10541163
-
项目类别:
-
资助金额:$70.33万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization
-
批准号:10669544
-
项目类别:
-
资助金额:$64.56万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
B-Cell Epitope Discovery and Mechanisms of Antibody Protection: Genetic and Structural Basis for Influenza Neutralization
-
批准号:10903692
-
项目类别:
-
资助金额:$64.56万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Project 2 - Vanderbilt University
-
批准号:10362732
-
项目类别:
-
资助金额:$80.23万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses
-
批准号:10564151
-
项目类别:
-
资助金额:$246.43万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Project 2 - Vanderbilt University
-
批准号:10581502
-
项目类别:
-
资助金额:$55.67万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION
-
批准号:10706905
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2019
-
负责人:James E Crowe
-
依托单位:
Human neutralizing antibodies for Zika virus
-
批准号:9219776
-
项目类别:
-
资助金额:$132.79万
-
财政年份:2017
-
负责人:James E Crowe
-
依托单位:
Human neutralizing antibodies for Zika virus
-
批准号:10082297
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2017
-
负责人:James E Crowe
-
依托单位:
Structural and functional basis of ultra potent CHKV neutralization by human mAbs
-
批准号:8894218
-
项目类别:
-
资助金额:$76.18万
-
财政年份:2015
-
负责人:James E Crowe
-
依托单位:
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses
-
批准号:8814174
-
项目类别:
-
资助金额:$171.19万
-
财政年份:2015
-
负责人:James E Crowe
-
依托单位:
PROJECT 4: Genetic and Structural Basis for Human Antibody Inhibition of Dengue Viruses
-
批准号:10244879
-
项目类别:
-
资助金额:$40.08万
-
财政年份:2015
-
负责人:James E Crowe
-
依托单位:
GENETIC & STRUCTURAL BASIS FOR INFLUENZA VIRUS NEUTRALIZATION
-
批准号:9570367
-
项目类别:
-
资助金额:$261.68万
-
财政年份:2014
-
负责人:James E Crowe
-
依托单位:
Hybrid Methods for Prediction and Design of Novel Human Influenza Antibodies
-
批准号:8919482
-
项目类别:
-
资助金额:$43.33万
-
财政年份:2014
-
负责人:James E Crowe
-
依托单位:
海外基金